Author(s): A. Porselvi


DOI: 10.5958/0974-360X.2021.00090.1   

Address: A. Porselvi*
School of Pharmacy, Sathyabama Institute of Science and Technology, Chennai – 600119, India.
*Corresponding Author

Published In:   Volume - 14,      Issue - 1,     Year - 2021

Clinical pharmacy is a health care discipline which focuses on clinical pharmacist’s involved patient care programmes to provide rationality in drugs use, to improve health and prevention and management of diseases. Clinical pharmacist directly can communicate with health care professionals and can resolve various health care issues related to patients. Clinical pharmacy services in the hospitals includes detecting of drug interactions, adverse drug events monitoring and filing, effective patient counselling, patient education, providing drug information services, monitoring of drug therapy, creating disease prevention and management awareness in the clinical setup. Diabetes mellitus is a chronic metabolic disease associated with elevated blood sugar levels which ultimate causes damage of vital organs of the human body. In western countries the practice of clinical pharmacy and education services for non-communicable diseases are well established effectively. In India, clinical pharmacy services are still to be flourished with advancement in delivering of high standard pharmaceutical care and effective clinical services in all the tertiary care hospital settings. This review mainly aimed to highlight the western practices of advanced clinical pharmacy services and to bring into limelight the same in Indian, the clinical pharmacy practice for a better health outcome for the future.

Cite this article:
A. Porselvi. A Review on the Need of Advanced Clinical Pharmacy Education Services for Diabetes Prevention and Management in India in comparison with International Standards. Research J. Pharm. and Tech. 2021; 14(1):493-500. doi: 10.5958/0974-360X.2021.00090.1

A. Porselvi. A Review on the Need of Advanced Clinical Pharmacy Education Services for Diabetes Prevention and Management in India in comparison with International Standards. Research J. Pharm. and Tech. 2021; 14(1):493-500. doi: 10.5958/0974-360X.2021.00090.1   Available on:

1.    Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes-estimates for the year 2000 and Projections for 2030. Diabetes Care. 2004; 27(3):1047–53.
2.    Whiting Dr, Guariguata L, Weil C, Shawj. IDF Diabetes atlas: Global estimates of the prevalence of diabetes for 2011 and 2030. Diabetes Res Clin Pract. 2011; 94:311–21.
3.    Joshi SR, Parikh RM et al. India - diabetes capital of the world: now heading towards hypertension. J Assoc Physicians India. 2007; 55:323–4.
4.    Kumar A, Goel MK, Jain RB, et al. India towards diabetes control: Key issues. Australas Med J. 2013;6(10):524–31.
5.    UHC (2010) Pharmacy practice model for academic medical centers. In: consortium UH. oak book.
6.    ACCP(2012)Desired Professional Development Path ways for Clinical Pharmacists. American College of Clinical Pharmacy 33:e34-e42.
7.    American Diabetes Association. Economic Consequences of Diabetes Mellitus in the U.S. in 1997. Diabetes Care 1998; 21:296-309.
8.    International Diabetes Federation, World Health Organization. The Economics of Diabetes and Diabetes Care. Brussels: International Diabetes Federation, 1996.
9.    Anjana RM, Ali MK, Pradeepa R et al .The need for obtaining accurate nationwide estimates of diabetes prevalence in India - rationale for a national study on diabetes. Indian J Med Res. 2011 Apr; 133():369-80.
10.    Rao CR, Kamath VG. A cross-sectional analysis of obesity among a rural population in coastal Southern Karnataka, India. Australas Med J. 2011; 4(1):53-7.
11.    Mohan V, Shah S, Saboo BJ et al. Current glycemic status and diabetes related complications among type 2 diabetes patients in India: data from the A1chieve study. Assoc Physicians India. 2013 Jan; 61(1 Suppl):12-5.
12.    Legesse M, Teklay G, Fikadu D, et al. Clerkship guideline for undergraduate  pharmacy students. In: Mekelle, Mekelle University College of Health Sciences Department of Pharmacy. (2012).
13.    Giberson S, CDR Yoder S, CDR P Lee M (2011) Improving Patient and Health System Outcomes through advanced Pharmacy Practice. In: A Report to the US Surgeon General, RADM.
14.    Recognition of advanced pharmacy practice in Australia (2010) In: Competency Standards Review Steering Committee RPSGB.
15.    Wubben DP, Vivian EM et al. Effects of pharmacist outpatient interventions on adults with diabetes mellitus: a systematic overview. Pharmacotherapy. 2008;28(4):421–436.
16.    ACCP (2008) The Definition of Clinical Pharmacy. Pharmacotherapy. 28: 816-817.
17.    Veterans Health Administration (2015) Clinical pharmacy services. In: Affairs DoV. Washington.
18.    Mohan V, Seshiah V, Sahay BK et al. Current status of management of diabetes and glycaemic control in India: Preliminary results from the Diabcare India 2011 Study. Diabetes.2012; 61:a645–a677.
19.    Misra A, Khurana LInt et al. Obesity-related non-communicable diseases: South Asians vs White Caucasians. J Obes (Lond). 2011 Feb; 35(2):167-87.
20.    Unnikrishnan RI, Anjana RM, Mohan V et al. Importance of Controlling Diabetes Early–The Concept of Metabolic Memory, Legacy Effect and the Case for Early Insulinisation. JAPI (Suppl) 2011; 50:8–12.
21.    Kaveeshwar SA, Cornwall J. The current state of diabetes mellitus in India. AMJ 2014, 7, 1, 45-48.
22.    Global Burden of Metabolic Risk Factors for Chronic Diseases Collaboration. Cardiovascular disease, chronic kidney disease, and diabetes mortality burden of cardiometabolic risk factors from 1980 to 2010: a comparative risk assessment. Lancet Diabetes Endocrinol 2014; 2: 634–47.
23.    Seuring T, Archangelidi O, Suhrcke M et al. The economic costs of type 2 diabetes: a global systematic review. Pharmacoeconomics 2015; 33: 811–31
24.    WHO (2006) Developing pharmacy practice: A focus on patient care. In: Standards DoMPa Geneva, Switzerland FIP.
25.    West J, Amey J, Knapton C, Illing S (2012) Clinical pharmacy in general practice Midlands Health Network.
26.    SHPA (2005) Standards of Practice for Clinical Pharmacy. J Pharm Pract Res 35: 122-146.
27.    Council on Credentialing in Pharmacy (2009) Scope of Contemporary Pharmacy Practice: Roles, Responsibilities, and Functions of Pharmacists and Pharmacy Technicians. In: Pharmacy TCoCi, Washington, DC.
28.    Carter BL, Elliott WJ. The role of pharmacists in the detection, management, and control of hypertension: a national call to action. Pharmacotherapy. 2000; 20:119–122.
29.    Carter BL, Helling DK. Ambulatory care pharmacy services: the incomplete agenda. Ann Pharmacother. 1992; 26:701–708.
30.    Pharmacy NBO (2008) Pharmacy NAoBo: Model State Pharmacy Act and Model Rules of the 3.
31.    Implementation of Advances and Challenges in Clinical Pharmacy (2015) In: 3rd International Conference on Clinical Pharmacy. Atlanta, USA.
32.    Toronto UO (2015) Advanced Pharmacy Practice Experience. In: Toronto Uo.
33.    WSOP (2015) Advanced Pharmacy Practice Experiences (APPE) Manual.
34.    Pharmacy TUoGCo (2014) Introductory Pharmacy Practice Experience (IPPE) and Advanced Pharmacy Practice Experience (APPE) Manual.
35.    Belfast QU   (2013)   MSc   in   Advanced   Pharmacy   Practice   with Independent Prescribing.
36.    TTUHSC SOP (2012) Introduction to Pharmacy Practice. In: Amarillo.
37.    University of Houston (2014) Advanced hospital pharmacy practice experience course description. In: UoHCo.
38.    AAU (2009) Pharmacy course syllabus. School of pharmacy, University J.
39.    Mekonnen  AB, Yesuf EA, Odegard PS et al. (2013) Implementing ward based clinical pharmacy services in an Ethiopian University Hospital. Pharmacy Practice 11: 51-57.
40.    AAU (2010) Pharmacy practice course syllabus. School of Pharmacy.
41.    Janet PE, Brian LE, Douglas CA et al. (2013) Minimum Qualifications for Clinical Pharmacy Practice Faculty. In: ACoC.
42.    ACCP (2004) Guidelines for Clinical Research Fellowship Training Programs. In: The ACCP Board of Regents.
43.    Kumar A. Insulin guidelines: taking it forward. Medicine Update (API India). 2010;20:127–30.
44.    Unnikrishnan RI, Anjana RM, Mohan V et al. Importance of Controlling Diabetes Early–The Concept of Metabolic Memory, Legacy Effect and the Case for Early Insulinisation. JAPI (Suppl) 2011;50:8–12.
45.    Sui Z, Turnbull D et al. Enablers of and barriers to making healthy change during pregnancy in overweight and obese women. Australas Med J. 2013;6(11):565–77.
46.    Minnie Au, Rattigan S et al. Barriers to the management of Diabetes Mellitus – is there a future role for Laser Doppler Flowmetry? Australas Med J. 2012; 5(12):627–32.
47.    Verma R, Khanna P et al. National programme on prevention and control of diabetes in India: Need to focus. Australas Med J. 2012;5(6):310–5.
48.    State-based diabetes prevention and control program. Centers for Disease Control and Prevention. U.S Department of Health & Human Services. 2013 Accessed on 13 Dec. 2013.
49.    National Diabetes Education Program. Centers for Disease Control and Prevention. Accessed on 13 Dec. 2013.
50.    Authoritative Institute of Health and Welfare (AIHW) National health priority areas. 2013 Accessed on 13 Dec. 2013.
51.    Ali M, Knight A. Comparative healthcare: Diabetes Mellitus. Australas Med J. 2009;1(5):1–9.
52.    National service frameworks and strategies. National Health Services. 2011 Jul; Accessed on 13 Dec. 2013.
53.    Mathew E, Ahmed M, Hamid S et al. Hypertension and dyslipidaemia in Type 2 diabetes mellitus in United Arab Emirates. Australas Med J. 2010;3(11):699–706.
54.    Auta A, Maz J et al. Perceived facilitators to change in hospital pharmacy practice in England.  International   Journal of Clinical Pharmacy2015, 37: 1068-1075.
55.    Delgado O,  Kernan  WP et al. Advancing  the  pharmacy practice model in a community teaching hospital by expanding student rotations. American Journal of Health-System Pharmacy AJHP: Official Journal of the American society of Health-System  Pharmacists 2014,71: 1871-1876.
56.    Woolley AB, Berds C, Edwards RA et al. Potential cost avoidance of pharmacy students’ patient care activities during advanced pharmacy practice experiences. Am J Pharm Educ2013.77: 164.
57.    Assemi  M,  Corelli  RL et al. (2011)  Development  needs  of volunteer pharmacy practice preceptors. Am J Pharm Educ 75: 10.
58.    Keresztes JM  (2010)  Education. A  must  in  all  levels of  pharmacy practice. The Annals of Pharmacotherapy 44: 1826-1828.
59.    Rickles NM, Brown TA, McGivney MS et al. (2010) Adherence: A Review of education, research, practice, and policy in the United States. Pharm Pract (Granada) 8: 1-17.
60.    Slazak EM, Zurick GM (2009) Practice-based learning experience to develop residents as clinical faculty members. American Journal of Health-system Pharmacy AJHP: Official Journal of the American Society of Health-System Pharmacists 66: 1224-1227.
61.    Kheir  N,  Zaidan  M,  Younes H,  et  al. (2008) Pharmacy education and practice in 13 Middle Eastern countries. Am J Pharm Educ 72: 133.
62.    Gong   SD,   Millares   M et al.  (1992)   Drug   information pharmacists at health-care facilities, universities, and pharmaceutical companies. American Journal of Hospital Pharmacy 49: 1121-1130.
63.    Vollman  KE, Adams  CB, Shah MN et al.(2015) Survey of Emergency Medicine Pharmacy  Education  Opportunities  for Students and Residents. Hospital Pharmacy 50: 690-699.
64.    Butt  F, Ream E (2016) Implementing  oral  chemotherapy  services in community pharmacies: a qualitative study of chemotherapy nurses' and pharmacists' views. The International Journal of Pharmacy Practice 24: 149-159.
65.    Sriram D, McManus A, Emmerton L et al. (2015) Will Australians pay for health care advice from a community pharmacist? A video vignette study.  Research in Social and Administrative  Pharmacy RSAP 11: 579-583.
66.    Rickles NM, Skelton JB, Davis J et al. (2014) Cognitive memory screening and referral program in community pharmacies in the United States. International Journal of Clinical Pharmacy 36: 360-367.
67.    Warshany  K, Sherrill CH,  Cavanaugh  J et al. (2014) Medicare annual wellness visits conducted by a pharmacist in an internal medicine  clinic. American  journal  of health-system  pharmacy  AJHP: Official Journal of the American Society of Health-System Pharmacists 71: 44-49.
68.    McKee BD, Larose-Pierre M et al. (2015) A survey of community pharmacists and final-year student pharmacists and their perception of psychotherapeutic agents. Journal of Pharmacy Practice 28: 166-174.
69.    O'Connor SK, Ferreri SP, Michaels NM et al. (2012) Making pharmacogenetic  testing a reality in  a community  pharmacy. JAPHA 52: e259-e265.
70.    Hardin HC, Hall AM, Roane TE et al.(2012) An advanced pharmacy practice experience in a student-staffed medication therapy management call center. Am J Pharm Educ 76: 110.
71.    Bosse N, Machado M et al. (2012) Efficacy of an over-the-counter intervention  follow-up program in community pharmacies. JAPHA 52: 535-540.
72.    Hata  M,  Klotz R, Sylvies R et  al. (2012) Medication therapy management services provided by student pharmacists. Am J Pharm Educ 76: 51.
73.    Mandt   I, Horn   AM,  Ekedahl  A et al. (2010)  Community pharmacists' prescription  intervention  practices-exploring variations in practice in Norwegian pharmacies. RSAP 6: 6-17.
74.    Blake KB et al. (2010) Perceived barriers to provision of medication therapy management services (MTMS) and the likelihood of a pharmacist to work in a pharmacy that provides MTMS. The Annals of Pharmacotherapy 44: 424-431.
75.    Salter  C  (2010)  Compliance   and   concordance   during   domiciliary medication review involving pharmacists and older people. Sociology of Health and Illness 32: 21-36.
76.    Bolt J, Semchuk W, Loewen P et al. (2015) A Canadian Survey of Pharmacist Participation during Cardiopulmonary Resuscitation. The Canadian Journal of Hospital Pharmacy 68: 290-295.
77.    Grindrod  KA, Marra CA, Colley L et al. (2010) Pharmacists'   preferences  for   providing   patient-centered   services:  a discrete choice experiment to guide health policy. The Annals of Pharmacotherapy 44: 1554-1564.
78.    Karralli R, Tipton J, Dumitru  D et al. (2015) Development of a metrics dashboard for monitoring involvement in the 340B Drug Pricing Program. American Journal of Health-System Pharmacy. AJHP: Official Journal of the American Society of Health- System Pharmacists 72: 1489-1495.
79.    Lancaster JW, Douglass MA, Gonyeau MJ et al. (2013) Providers' perceptions of student pharmacists on inpatient general medicine practice experiences. Am J Pharm Educ 77: 26.
80.    Rovers J, Miller MJ, Koenigsfeld Cet al. (2011) A guided interview process to improve student pharmacists' identification of drug therapy problems. Am J Pharm Educ 75: 16.
81.    Stacey SR, Coombes I, Wainwright C et al. (2015) What does advanced practice  mean  to  Australian  pediatric  pharmacists? A focus group study. The International Journal of Pharmacy Practice 23: 141-149.
82.    Swetenham K, Rowett D, Stephenson D (2014) Clinical networks influencing policy and practice: the establishment of advanced practice pharmacist roles for specialist palliative care services in South Australia. Australian Health Review: Australian Hospital Association 38: 238-241.
83.    Walker KA, Scarpaci L, McPherson ML (2010) fifty reasons to love your palliative care pharmacist. The American Journal of Hospice & Palliative Care 27: 511-513.
84.    Eric Gilliam, Wesley Nuffer, Megan Thompson et al. Design and activity evaluation of an Advanced-Introductory Pharmacy Practice Experience (AIPPE) course for assessment of student APPE readiness. Currents in Pharmacy Teaching and Learning. Volume 9, Issue 4, July 2017, Pages 595-604.
85.    Erini S. Serag-Bolos, Aimon C et al. Assessing students knowledge regarding the roles and responsibilities of a pharmacist with focus on care transitions through simulation.. Currents in Pharmacy Teaching and Learning .Volume 9, Issue 4, July 2017, Pages 616-625
86.    Andrew R. Miesner, Wesley Lyons et al. Educating medical residents through podcasts developed by PharmD students. Currents in Pharmacy Teaching and Learning .Volume 9, Issue 4, July 2017, Pages 683-688.
87.    Tatummead stephanies chauner. Pharmacy student engagement in the evaluation of medication documentation within an ambulatory care electronic medical record. Currents in Pharmacy Teaching and Learning. Volume 9, Issue 3, May 2017, Pages 415-420.
88.    Lindsey B. Amerine John M. Valgus Joseph D et al . Implementation of a longitudinal early immersion student pharmacist health system internship program. Currents in Pharmacy Teaching and Learning. Volume 9, Issue 3, May 2017, Pages 421-426.
89.    Karen M.S. BastianelliLucas Nelsonlaura palombi et al. Perceptions of pharmacists’ role in the health care team through student-pharmacist led point-of-care screenings and its future application in health care. Currents in Pharmacy Teaching and Learning. Volume 9, Issue 2, March–April 2017, Pages 195-200.
90.    Shawn Riser Tayl, Michelle DeGeeter, et al. Preceptor perceptions of fourth year student pharmacists’ abilities regarding patient counseling on therapeutic lifestyle changes. Currents in Pharmacy Teaching and Learning. Volume 8, Issue 3, May–June 2016, Pages 353-358.
91.    Sharvari Dilip Malshe et al. Waist-to-Height Ratio in Indian Women: Comparison with Traditional Indices of Obesity, Association with Inflammatory Biomarkers and Lipid Profile. Asia Pacific Journal of Public Health. Vol 29, Issue 5, pp. 411 – 421,2017. 10.1177/1010539517717509.
92.    Michiyo Higuchi et al. Access to Diabetes Care and Medicines in the Philippines. Asia Pacific Journal of Public Health. Vol 22, Issue 3_suppl, pp. 96S - 102S.2010. 10.1177/1010539510373005.
93.    A. Porselvi, M.S. Uma Shankar, K.S. Lakshmi, A. Bharath Kumar. Comprehensive Review on Diabetic Foot Ulcer – A Brief Guide to Pharmacists. International Journal of Chem Tech Research. Vol.10 No.9, pp843-851, 2017.
94.    A. Porselvi, M.S. Uma Shankar, K.S. Lakshmi. A Retrospective Qualitative Study on Current Diabetic Foot Ulcer Management and Discussion on Extended Role of Clinical Pharmacist Marmara Pharmaceutical Journal 21/2: 412-418, 201.
95.    Ashwitha Shruti Dass, Sarala Narayana, P. N. Venkatarathnamma. Effect of Vitamin E and omega 3 fatty acids in type 2 diabetes mellitus patients. Journal of Advanced Pharmaceutical Technology & Research. 9; 1: January March 2018.

Recomonded Articles:

Research Journal of Pharmacy and Technology (RJPT) is an international, peer-reviewed, multidisciplinary journal.... Read more >>>

RNI: CHHENG00387/33/1/2008-TC                     
DOI: 10.5958/0974-360X 

56th percentile
Powered by  Scopus

SCImago Journal & Country Rank

Recent Articles


Not Available